Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Watson

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmacoepidemiology and Drug Safety|March 2, 2006
Observational studies and the withdrawal of rofecoxibDouglas J Watson, Nancy C Santanello
Journal of Health and Human Services Administration|February 12, 2005
Evaluating emergency medical services: controlling the rising cost of saving livesJerry Davis, Roseann Kuhns, Douglas J Watson
The Journal of Rheumatology|June 5, 2003
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research DatabaseDouglas J Watson, Thomas Rhodes, Harry A Guess
The Journal of Rheumatology|April 17, 2009
Serum urate during acute goutNaomi Schlesinger, Josephine M Norquist, Douglas J Watson
Drug Safety|December 30, 2006
Increase in nonfatal digestive perforations and haemorrhages following introduction of selective NSAIDs: a public health concernDouglas J Watson, Elham Rahme, Nancy C Santanello
Clinical Therapeutics|February 27, 2009
Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interviewSachin Kamal-Bahl, Douglas J Watson, Baishali M Ambegaonkar
Pharmacoepidemiology and Drug Safety|May 1, 2012
An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network databaseBing Cai, Weifeng Xu, Edward Bortnichak, et al.
Archives of Internal Medicine|May 22, 2002
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritisDouglas J Watson, Thomas Rhodes, Bing Cai, et al.
Current Medical Research and Opinion|August 24, 2007
Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertensionAlan Morrison, Dena Rosen Ramey, Janet van Adelsberg, et al.
Annals of Internal Medicine|May 6, 2004
Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritisJames M Pellissier, Douglas J Watson, Sheldon X Kong, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|March 2, 2006
Observational studies and the withdrawal of rofecoxibDouglas J Watson, Nancy C Santanello
Journal of Health and Human Services Administration|February 12, 2005
Evaluating emergency medical services: controlling the rising cost of saving livesJerry Davis, Roseann Kuhns, Douglas J Watson
The Journal of Rheumatology|June 5, 2003
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research DatabaseDouglas J Watson, Thomas Rhodes, Harry A Guess
The Journal of Rheumatology|April 17, 2009
Serum urate during acute goutNaomi Schlesinger, Josephine M Norquist, Douglas J Watson
Drug Safety|December 30, 2006
Increase in nonfatal digestive perforations and haemorrhages following introduction of selective NSAIDs: a public health concernDouglas J Watson, Elham Rahme, Nancy C Santanello
Clinical Therapeutics|February 27, 2009
Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interviewSachin Kamal-Bahl, Douglas J Watson, Baishali M Ambegaonkar
Pharmacoepidemiology and Drug Safety|May 1, 2012
An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network databaseBing Cai, Weifeng Xu, Edward Bortnichak, et al.
Archives of Internal Medicine|May 22, 2002
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritisDouglas J Watson, Thomas Rhodes, Bing Cai, et al.
Current Medical Research and Opinion|August 24, 2007
Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertensionAlan Morrison, Dena Rosen Ramey, Janet van Adelsberg, et al.
Annals of Internal Medicine|May 6, 2004
Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritisJames M Pellissier, Douglas J Watson, Sheldon X Kong, et al.
Pageof 4